Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-37.7M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$376M
-
Number of sells
-
-129
Significant Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q3 2025
136 filings reported holding ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2025.
iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 38M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Farther Finance Advisors, LLC (0 shares), HARBOR CAPITAL ADVISORS, INC. (0 shares), CWM, LLC (0 shares), Regency Capital Management Inc.\DE (0 shares), True Wealth Design, LLC (0 shares), KLP KAPITALFORVALTNING AS (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), Campbell & CO Investment Adviser LLC (0 shares), AMALGAMATED BANK (0 shares), and GAMMA Investing LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.